ERNA vs VICI · P/E 0.0, rev $582.0K vs P/E 9.3, rev $3.85B
Eterna Therapeutics Inc (ERNA) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the ERNA and VICI stock pages for the full models.
Not investment advice.